PT Pyridam Farma Tbk (ISX:PYFA) Total Liabilities : Rp4,693,922 Mil (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is PT Pyridam Farma Tbk Total Liabilities?

PT Pyridam Farma Tbk's Total Liabilities for the quarter that ended in Sep. 2024 was Rp4,693,922 Mil.

PT Pyridam Farma Tbk's quarterly Total Liabilities increased from Mar. 2024 (Rp1,600,449.40 Mil) to Jun. 2024 (Rp4,812,604.00 Mil) but then declined from Jun. 2024 (Rp4,812,604.00 Mil) to Sep. 2024 (Rp4,693,922.00 Mil).

PT Pyridam Farma Tbk's annual Total Liabilities increased from Dec. 2021 (Rp639,121.01 Mil) to Dec. 2022 (Rp1,078,211.17 Mil) and increased from Dec. 2022 (Rp1,078,211.17 Mil) to Dec. 2023 (Rp1,164,172.96 Mil).

PT Pyridam Farma Tbk Total Liabilities Historical Data

The historical data trend for PT Pyridam Farma Tbk's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Pyridam Farma Tbk Total Liabilities Chart

PT Pyridam Farma Tbk Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

66,060.22

70,943.63

639,121.01

1,078,211.17

1,164,172.96

PT Pyridam Farma Tbk Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															1,161,390.15	1,164,172.96	1,600,449.40	4,812,604.00	4,693,922.00

PT Pyridam Farma Tbk Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PT Pyridam Farma Tbk's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	293714.678	+	(835557.277	+	-0.0010000000693253
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	34901.002)
	=	1,164,173

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1521232.66	-	357059.704
	=	1,164,173

PT Pyridam Farma Tbk's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2319861	+	(2082944	+	131037
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	160080)
	=	4,693,922

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	5892993	-	1199071
	=	4,693,922

PT Pyridam Farma Tbk Total Liabilities Related Terms

Thank you for viewing the detailed overview of PT Pyridam Farma Tbk's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Pyridam Farma Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Pyridam Farma Tbk (ISX:PYFA) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jl. Gen. Sudirman No. Kav. 21, Sinarmas MSIG Tower 12th Floor, RT.10/RW.1, Kuningan, Karet, Setiabudi District, South Jakarta City, Jakarta, IDN, 12920

Website

https://www.pyfa.co.id

PT Pyridam Farma Tbk is an Indonesia-based company, engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through the following segments: Pharmaceutical Products and Toll Manufacturing Services; and Medical Device Products. The company derives maximum revenue from Pharmaceutical Products and Toll Manufacturing Services. The company's products include consumer health, Derma, prescription, and biomedilab.

PT Pyridam Farma Tbk Headlines

No Headlines